Covishield vaccine

The Kerala HC has sought the Centre's response over a plea regarding a post-Covid-19 vaccination death. The post-mortem report of the deceased confirmed that death was due to intracranial bleeding. The Medical officer suspects that it was a case of thrombosis-with-thrombocytopenia-syndrome (TTS), a  rare but well-known adverse event associated with the adenovirus vector-based Covishield vaccine. The plea argues that the victim had not been… read-more

Pune based Serum Institute of India (SII) on February 4, wrote to Union Health Minister Mansukh Mandaviya, to reduce booster dose gap from nine months to three. The SII Director and Government Affairs official Prakash Kumar Singh, further asked to allow Covishield precaution dose for all above 18-years-old. The letter was written on the lines of revised guidelines, allowing booster dose for people on election duties with three months gap. … read-more

Adar Poonwalla, CEO of the Serum Institute of India (SII) applied for full market authorisation of its COVID-19 vaccine, Covishield, on December 31. "Supplies of Covishield vaccine in India, exceeded 1.25 billion doses. The Government of India now has enough data to allow full market authorisation," tweeted SII CEO. The application has been submitted to the Union Government and MoHFW. Besides, SII's Covishield also export vaccine doses to… read-more

According to research, the COVID antibodies response is better when there is an interval of 44-45 weeks between the first and second doses of Oxford-Covishield-Vaccine. “The encouraging results support a strategy of delayed second dosing because antibody titres (concentration) were substantially higher after the second dose among individuals with almost a year between doses than among individuals who had an 8–12 week interval," says the… read-more

After India's formal request & threaten with mandatory quarantine, the seven EU nations have now agreed on June 1 to include Covishield & Covaxin in the Green Pass list. Switzerland, Iceland, and other EU nations - Austria, Germany, Slovenia, Greece, Ireland, Estonia, and Spain have accepted the Indian Serum Institute-manufactured Covishield vaccine for travel. However, Covaxine is yet to be cleared by WHO.